HIGHLIGHTS
- who: Yoshikazu Nagase from the Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, u2011, Yamadaoka, Suita, Osaka, u20110871, Japan have published the article: Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer, in the Journal: (JOURNAL)
- what: The authors focused on lipolysis-stimulated receptor (LSR) a membrane highly expressed in EC cells and developed a chimeric chicken-mouse anti-LSR monoclonal antibody (mAb). This study investigated the antitumor effect of an anti-LSR mAb and the function of LSR in EC. The authors focused on LSR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.